Acquisition Announced
Shionogi & Co. acquisition of Shionogi-Apnimed Sleep Science
US$100m consideration
Announced 29 Apr 2026
Advisers
Shionogi-Apnimed Sleep Science
Target
- Legal adviser
Shionogi & Co.
Acquirer
Not disclosed
- Target
- Shionogi-Apnimed Sleep Science
- Acquirer
- Shionogi & Co.
- Seller
- Apnimed
- Buyer based in
- Japan
- Seller based in
- United States
- Stake
- 50%
- Sector
- Pharma
- Tags
- Pharma, Drug Development
In the league tables
Similar deals
- Tarsus Pharmaceuticals acquisition of iRenix Medical Jul 2026 · US$75m · Ophthalmology
- Amneal Pharmaceuticals acquisition of Kashiv BioSciences Apr 2026 · US$375m · Biotech
- Veloxis Pharmaceuticals acquisition of AiCuris Anti-infective Cures AG Feb 2026 · US$913m · Pharma
- Eli Lilly and Company acquisition of Ventyx Biosciences Jan 2026 · US$1.2bn · Biotech
- Hansoh Pharmaceutical Group Co. stake in Avere Therapeutics Jul 2026 · Biotech
